Increased sensitivity to gemcitabine of P-gP and MRP overexpressing human non-small cell lung cancer cell lines.
Bergman
A M
AM
Department Medical Oncology, Free University Hospital, Amsterdam, The Netherlands.
Pinedo
H M
HM
Veerman
G
G
Kuiper
C M
CM
Peters
G J
GJ
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000096:biosynthesis*; D018528:ATP-Binding Cassette Transporters / Q000096:biosynthesis*; D000964:Antimetabolites, Antineoplastic / Q000633:toxicity*; D002289:Carcinoma, Non-Small-Cell Lung; D003630:Daunorubicin / Q000633:toxicity; D003841:Deoxycytidine / Q000031:analogs & derivatives* / Q000633:toxicity; D004317:Doxorubicin / Q000633:toxicity; D018432:Drug Resistance, Multiple; D006801:Humans; D008175:Lung Neoplasms; D027425:ATP-Binding Cassette, Sub-Family C Proteins; D014407:Tumor Cells, Cultured; D000093542:Gemcitabine
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D018528:ATP-Binding Cassette Transporters; D000964:Antimetabolites, Antineoplastic; D003630:Daunorubicin; D003841:Deoxycytidine; D004317:Doxorubicin; D027425:ATP-Binding Cassette, Sub-Family C Proteins; D000093542:Gemcitabine